Keith Katkin Insider Trading $ELDN Eledon Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Keith Katkin.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Keith Katkin. Keith Katkin is Sr. V.P. of Sales & Marketing in AVANIR PHARMACEUTICALS, INC. ($AVNR) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in Carbylan Therapeutics, Inc. ($CBYL) and in Syndax Pharmaceuticals Inc ($SNDX) and Director in Novus Therapeutics, Inc. ($NVUS) and PEO;CEO-Urovant Sciences,Inc. in Urovant Sciences Ltd. ($UROV) and PEO;CEO/Urovant Sciences, Inc. in Urovant Sciences Ltd. ($UROV).

Keith Katkin in Eledon Pharmaceuticals, Inc.

Trading Symbol: ELDN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith Katkin: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 15 2020
$ELDN Market Capitalization: $20.25M
$ELDN Previous Close: $0.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Keith Katkin in Eledon Pharmaceuticals, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AVNR, ELDN, KALV, RIGL, SNDX, UROV

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Sep 15 2020	NVUS	Novus Therapeutics ...	Katkin Keith	Director	Option Exercise	A	500.00	5,907	2,953,500	5,907
Jul 15 2019	NVUS	Novus Therapeutics ...	Katkin Keith	Director	Option Exercise	A	0.88	20,000	17,600	20,000
Jun 14 2018	NVUS	Novus Therapeutics ...	Katkin Keith	Director	Option Exercise	A	6.18	9,100	56,238	9,100

Page: 1